CochLear (OTCMKTS:CHEOY - Get Free Report) was downgraded by stock analysts at UBS Group from a "strong-buy" rating to a "hold" rating in a research note issued on Thursday,Zacks.com reports.
Several other brokerages have also recently commented on CHEOY. Royal Bank Of Canada upgraded shares of CochLear from a "hold" rating to a "moderate buy" rating in a report on Monday, January 19th. Zacks Research upgraded shares of CochLear to a "hold" rating in a report on Friday, April 17th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, CochLear currently has a consensus rating of "Moderate Buy".
Read Our Latest Stock Report on CHEOY
CochLear Stock Up 2.5%
Shares of CHEOY opened at $34.67 on Thursday. CochLear has a 12-month low of $33.56 and a 12-month high of $105.60. The firm's 50 day moving average is $61.43 and its 200-day moving average is $80.34.
About CochLear
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
